Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W X Foley

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pacing and Clinical Electrophysiology : PACE|March 16, 2019
Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillationFrancisco Leyva, Abbasin Zegard, Robin Taylor, et al.
Journal of the American College of Cardiology|October 2, 2012
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathyFrancisco Leyva, Robin J Taylor, Paul W X Foley, et al.
Journal of the American Heart Association|October 30, 2018
Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular PacingFrancisco Leyva, Abbasin Zegard, Robin J Taylor, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2015
Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter RegistryJonathan M Behar, Julian Bostock, Adrian Po Zhu Li, et al.
JACC. Clinical Electrophysiology|March 11, 2017
Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK RegistryJonathan M Behar, Hui Men Selina Chin, Steve Fearn, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
European Heart Journal|May 21, 2023
Dapagliflozin vs. metolazone in heart failure resistant to loop diureticsSu Ern Yeoh, Joanna Osmanska, Mark C Petrie, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pacing and Clinical Electrophysiology : PACE|March 16, 2019
Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillationFrancisco Leyva, Abbasin Zegard, Robin Taylor, et al.
Journal of the American College of Cardiology|October 2, 2012
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathyFrancisco Leyva, Robin J Taylor, Paul W X Foley, et al.
Journal of the American Heart Association|October 30, 2018
Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular PacingFrancisco Leyva, Abbasin Zegard, Robin J Taylor, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2015
Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter RegistryJonathan M Behar, Julian Bostock, Adrian Po Zhu Li, et al.
JACC. Clinical Electrophysiology|March 11, 2017
Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK RegistryJonathan M Behar, Hui Men Selina Chin, Steve Fearn, et al.
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
European Heart Journal|May 21, 2023
Dapagliflozin vs. metolazone in heart failure resistant to loop diureticsSu Ern Yeoh, Joanna Osmanska, Mark C Petrie, et al.
Pageof 3